New York University's Langone Health is preparing for a giant leap in its infrastructure - an impressive $650 million expansion projected for its recently purchased hospital, located in Patchogue, Long Island. The monumental growth plans include a new 144-bed tower, an array of private rooms, a broadening of services, and an infusion of the latest…
Healthcare-associated infections (HAIs), such as central line-associated bloodstream infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs), are prominent threats to patient safety in medical facilities worldwide. They are not only detrimental to patient outcomes but also precipitate higher healthcare expenses due to extended hospital stays. Luckily, recent discoveries in evidence-based procedures, upgraded clinical protocols, and…
In a progressive step towards infection prevention, researchers have developed a novel central line-associated bloodstream infection (CLABSI) prevention bundle, termed as the 'Standard Assessment for Effective Response (SAFER) Lines'. The recent study asserts that this unique preventive measure notably lowered inflammation, infections, and subsequent hospitalizations among nursing home residents who had peripherally inserted central catheters…
GermZAPP, pioneered by Athela, LLC, offers a revolutionary approach to robust infection control through an innovative, cost-effective hand hygiene system. This system promises to significantly impact infection control in a variety of environments from schools, nursing homes, to healthcare settings. Through an exclusive interview with Infection Control Today®, Athela LLC's owner and founder, Lisa Broyden,…
UCI Health, California's only academic health system catering to the diverse population of Orange and sections of Los Angeles counties, along with its esteemed infectious disease authority, Dr. Susan Huang, were recently distinguished at the Greater Irvine Chamber Excellence in Healthcare & Innovation Awards. The recognition shines a spotlight on transformative infection prevention methodologies, leadership,…
Ondine Biomedical, a Canadian company specializing in life sciences, has declared that it is stepping up the final preparations to kick off its key US Phase 3 clinical trial in Q4 2024. This acceleration comes in the wake of a successful fundraiser that totalled Cdn $16 million (US $11m), attracting substantial support from existing institutional…
Leidos, a Fortune® 500 innovation company based out of Reston, Virginia, has recently been granted the National Healthcare Safety Network (NHSN) Development, Maintenance, Support and Modernization contract. The contract was bestowed upon the company by the Centers for Disease Control and Prevention's National Center for Emerging and Zoonotic Infectious Diseases. This crucial assignment worth a…
Market.us Media is dedicated to delivering the most trustworthy, up-to-the-minute data by employing a wide array of resources. This ranges from paid and complimentary outlets to first-hand research and telephonic interviews. Our objective is to provide reliable information to make informed personal or business choices. Consequently, we encourage the utilization of our data free of…
Ondine Biomedical Inc., a prominent innovator in the field of light-activated antimicrobial technology for hospital infection prevention and treatment, announced an impressive milestone. Steriwave® nasal decolonization, netted by Ondine Biomedical, is now operational across all of British Columbia's five health authorities.
The University Hospital of Northern British Columbia (UHNBC), a central hub renowned for specialized surgical…